NAMDIATREAM wins major European award
Riga, Latvia – Jun 11, 2015 – An EU funded nanotechnology project entitled NAMDIATREAM has been named the best project out of 1,000 at EuroNanoForum 2015, Europe’s largest nanotechnology convention.
NAMDIATREAM involves the development of nanotechnology-based tools to enable early detection and imaging of biomarkers of the most common cancer types. As a NAMDIATREAM member, Radisens has developed innovative optical detection technologies for the detection of specific biomarkers in blood.
The NAMDIATREAM consortium consists 22 partners across nine countries. It was the largest award made by the European Commission under the bio-application topic in the Seventh Framework (FP7) Nanosciences, Nanotechnologies, Materials and new Production Technologies (NMP) call. Coordinated by Trinity College Dublin, Radisens Diagnostics was one of seven SME’s who comprises the consortium.
Commenting on the award, Radisens’ CEO, Jerry O’Brien said that “this is a great recognition of the innovative technologies developed within NAMDIATREAM. With the optical detection technologies prototyped in this project, Radisens is expanding into assay and microfluidic development to develop proprietary sample-to-answer blood testing technologies”